End of April ?
At the same time, backlog has gone up hugely. Basically what we're seeing is growing pains. Bottom line is, revenues is increasing like crazy, and margins were at 20% last qtr. If they simply have the same revenues in the Mar qtr as the Dec qtr, with 20% margins, and no foulups, GV would post $.07 for the quarter. However I think they'll post $30M in revenues, and possibly $.08 for the quarter.
ri66- Can you please site exact method of illegal manipulation used yesterday and today to kill the rallies ? thanks
I would love to finally see a level playing feild.
If GV gets their act together, the company will start posting $.08+/qtr & be a $3.50-$4.00 stock. Without the foulup in the Dec qtr, they would have posted $.07.
What are you talking about. ri66 gave his credentials, cited the specific illegal manipulation, and says he will have a report going to the SEC.
I mean how many companies have estimates of 50% growth for 2015 & 2016 both !
How would you go about stopping this relentless selling of the stock ?
ri66- I strongly believe KERX is being manipulated, but I have nowhere near your expertise. Anything you can do to prove there is illegal manipulation going on, including naked shorting is greatly appreciated. KERX is doing great, script #s are increasing, and Auryxia has a bright future with possible FDA extension of the use of the drug for patients with early stage renal disease with anemia.
I believe the stock has been manipulated ever since FDA approval, but like I say, I can't prove anything. Again, if you can prove there is illegal manipulation going on, please do. thanks again.
prop- of course script #s matter. My past posts last week were just sarcasm. I mean shorts do seem to control the stock. I don't know how they're doing it, but it seems they are- at least for now. I added at $13.50, $13, $12.50, and again today at $12. Hopefully the script numbers were good for the week ended 3/27. Good luck
The shorts are heavily invested in keeping this stock down, and I believe the stock won't rally till KERX announces they've gotton the 60%+ insurers on board they said they would by end of April.
Isn't it like 6 of the last 7 qtrs have had these persistant mishaps with one contract of another ? It's getting to the point where it's hard to value the stock, as we don't know if the backlog has profits in it or not. If GV hadn't been around for so long, I would undersand better also. I mean hasn't the company been in the electrical construction market for like 50 years ? You'd think they would know when they're over bidding on contracts by now.